Balanced news tone
News Sentiment
RGT sentiment intelligence
Argent BioPharma Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+100.0% over one week, +94.6% over four weeks, trend inactive, and below fair value.
Argent Biopharma Taps ASX for A$262,000 via Convertible Notes and 5.1 Million Unlisted Options
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Argent Biopharma Taps ASX for A$262,000 via Convertible Notes and 5.1 Million Unlisted Options
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 06:31
- Source
- finance.biggo.com
Argent Biopharma (ASX: RGT) Falls 15% and Is Down Nearly a Quarter Over the Year: Is the Micro-Cap Biotech Facing a Difficult Path?
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 13 Jul 2026 13:48
- Source
- Kalkine
Price to sales forward of Argent Biopharma Ltd – ASX:RGT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 12:38
- Source
- TradingView
ASX Runners of the Week: Argent, Peregrine, Newpeak Metals & Caspin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 05:29
- Source
- The West Australian
Argent Biopharma (ASX: RGT) Jumps 13%: Is the Biotech Finding a Spark After a Difficult Year?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 04:25
- Source
- Kalkine
ASX-listed Argent BioPharma signs US$5.5M licensing deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 07 Jul 2026 04:46
- Source
- grafa.com
Argent BioPharma (ASX:RGT): Is CannEpil Global Licence Transformative Deal Worth Understanding?
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 07 Jul 2026 01:55
- Source
- Kalkine
Argent BioPharma (ASX:RGT) swaps CannEpil rights for US$5.5m in Mercer debt forgiveness
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 07 Jul 2026 00:54
- Source
- Stocks Down Under
Argent Biopharma (ASX:RGT): Could This Biotech Stock Become a Speculative Healthcare Play?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Kalkine
Argent Biopharma (ASX: RGT): Could This Biopharma Stock Become a High-Risk Watchlist Name?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Kalkine
Argent BioPharma advances epilepsy strategy with CannPal acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 13 Apr 2026 07:00
- Source
- BiotechDispatch
Argent secures CannPal stake
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 14 Jan 2026 08:00
- Source
- The Australian
Argent BioPharma secures significant financing facility to support strategic expansion
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Nov 2025 08:00
- Source
- BiotechDispatch
Transformative journey driving Argent BioPharma’s growth and US listing plans
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Sep 2025 07:00
- Source
- Stockhead
Runners of the Week: Kaili, Magnetite Mines, Argent Biopharma, Octava
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Aug 2025 07:00
- Source
- SMH.com.au
Argent BioPharma Jumps 86% After Bold AusCann Acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 19 Aug 2025 07:00
- Source
- Stocks Down Under
Argent acquires key AusCann assets
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Aug 2025 07:00
- Source
- The Australian
Argent BioPharma becomes latest tech firm to ditch the London Stock Exchange
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Nov 2024 08:00
- Source
- UKTN
RGT Stock Price and Chart — ASX:RGT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Apr 2024 02:52
- Source
- TradingView
Argent Biopharma Limited (ASX:RGT) - Shares, Dividends & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2024 18:19
- Source
- intelligentinvestor.com.au
MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Feb 2024 08:00
- Source
- BioSpace